Literature DB >> 1599523

Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis.

F M Wigley1, R A Wise, R Miller, B W Needleman, R J Spence.   

Abstract

OBJECTIVE: To determine the clinical and serologic risk factors for digital ischemic events in patients with systemic sclerosis (SSc).
METHODS: Retrospective review of clinical and laboratory data and review of current clinical status of 98 patients with SSc, seen between 1985 and 1990.
RESULTS: Amputation of 1 or more digits due to ischemia occurred in 20.4% of the patients; 9.2% had multiple digit loss. Sclerodactyly alone and anticentromere antibody (ACA) were associated with loss of 1 or more digits. Age, smoking status, duration of disease, or duration of Raynaud's phenomenon were not predictive for loss of digits.
CONCLUSION: Patients with limited SSc who are positive for ACA have an increased risk of major peripheral vascular occlusive disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1599523     DOI: 10.1002/art.1780350614

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  32 in total

1.  [Critical limb ischemia in systemic sclerosis].

Authors:  M O Becker; G Riemekasten
Journal:  Z Rheumatol       Date:  2012-06       Impact factor: 1.372

2.  Capillaroscopy: questions and answers.

Authors:  Walter Grassi; Rossella De Angelis
Journal:  Clin Rheumatol       Date:  2007-07-14       Impact factor: 2.980

3.  Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma.

Authors:  A C Gelber; S R Pillemer; B J Baum; F M Wigley; L K Hummers; S Morris; A Rosen; L Casciola-Rosen
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

4.  Anticentromere antibody--clinical associations. A study of 44 patients.

Authors:  P Caramaschi; D Biasi; T Manzo; A Carletto; F Poli; L M Bambara
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

Review 5.  Autoantibodies to components of the mitotic apparatus.

Authors:  J B Rattner; G J Mack; M J Fritzler
Journal:  Mol Biol Rep       Date:  1998-07       Impact factor: 2.316

6.  Finger skin temperature in patients affected by Raynaud's phenomenon with or without anticentromere antibody positivity.

Authors:  P Caramaschi; D Biasi; A Carletto; T Manzo; M Randon; S Zeminian; L M Bambara
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

7.  Clinical setting of patients with systemic sclerosis by serum autoantibodies.

Authors:  U Picillo; S Migliaresi; M R Marcialis; A M Ferruzzi; G Tirri
Journal:  Clin Rheumatol       Date:  1997-06       Impact factor: 2.980

Review 8.  Clinical relevance of autoantibodies in systemic rheumatic diseases.

Authors:  M J Fritzler
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

9.  Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1).

Authors:  Christopher A Mecoli; Jamie Perin; Jennifer E Van Eyk; Jie Zhu; Qin Fu; Andrew G Allmon; Youlan Rao; Scott Zeger; Fredrick M Wigley; Laura K Hummers; Ami A Shah
Journal:  Clin Rheumatol       Date:  2019-12-19       Impact factor: 2.980

10.  Digital ischemic loss in systemic sclerosis.

Authors:  Umaima Marvi; Lorinda Chung
Journal:  Int J Rheumatol       Date:  2010-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.